Table 2. Candidate AIPC progression genes.

Chr.1	Gene2	In gene3	Distance from TSS4	Up or downstream5	Expression6	P-value7	Vector8	Tissue9
7	OR2A14	No	3546	Downstream	Over	0.000145	γRV	Lung
8	FER1L6	No	11278	Upstream	Over	0.000242	γRV	Liver
12	TAOK3	Yes	9210	Downstream	Over	0.000657	γRV	Lung
1	MAN1A2	Yes	53962	Downstream	Under	0.002	LV	Lung, Liver
13	MBNL2	Yes	134465	Downstream	Under	0.002	γRV	Lung
1	SERBP1	Yes	180	Downstream	Over	0.008	γRV	Lung
8	PLEKHA2	Yes	53671	Downstream	Under	0.011	LV	Lung
9	SPTAN1	Yes	42111	Downstream	Under	0.015	LV	Lung
21	ADAMTS1	No	19479	Upstream	Under	0.021	LV	Lung
5	SLC30A5	No	16882	Upstream	Over	0.03	LV	Lung
16	ABCC1	Yes	181992	Downstream	Over	0.031	LV	Lung, Liver
13	SLC7A1	Yes	71506	Downstream	Over	0.046	γRV	Liver
1	SLC25A24	Yes	44414	Downstream	Under	0.049	γRV	Lung

1. Chromosome with vector provirus.

2. Gene tagged by vector provirus.

3. Indicates if the vector provirus is within the gene.

4. Vector provirus distance to the transcription start site (TSS).

5. Indicates if the vector provirus is upstream or downstream from the TSS.

6. Expression of the candidate gene in PC patient tissue from Oncomine™ analysis.

7. p-value from Oncomine™ analysis of expression between PC patient tissue and unaffected tissue.

8. Vector type used for insertional mutagenesis.

9. Tissue from which the metastasis was isolated.